Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
HCPLive
NOVEMBER 25, 2024
Emapalumab may improve outcomes in patients with MAS whose disease didn’t respond to steroid therapy and mitigate the need for more toxic therapies.
Let's personalize your content